King Pharmaceuticals Inc.

(NYSE:KG)

	Sep 30, 2008	Jun 30, 2008	Mar 31, 2008
Operating revenue
Total Revenue	388,445	396,851	432,033
Operating Revenue	388,445	396,851	432,033
Adjustments To Revenue	—	—	—
Cost Of Sales	131,160	133,990	151,159
Cost Of Sales With Depreciation	101,465	102,185	91,461
Gross Operating Profit	257,285	262,861	280,874
Operating Expenses
Research And Development Expenses	33,855	48,662	28,508
Selling General And Administrative Expenses	99,278	111,973	129,858
Advertising Expenses	—	—	—
Operating Income Before Depreciation	124,152	102,226	122,508
Operating Income	122,999	57,839	121,449
Depreciation	—	—	—
Depreciation Unreconciled	29,695	31,805	59,698
Amortization	—	—	—
Amortization Of Intangibles	—	—	—
Operating Income After Depreciation	124,152	102,226	122,508
Non Operating Expenses
Interest Expense	1,828	1,838	1,804
Pre Tax Income	128,257	65,139	132,570
Income Taxes	43,507	22,118	44,937
Minority Interest	—	—	—
Income Before Income Taxes	128,257	65,139	132,570
Net Income From Continuing Operations	84,750	43,021	87,633
Net Income From Discontinued Operations	—	—	—
Net Income From Total Operations	84,750	43,021	87,633
Non Recurring Events
Extraordinary Income Losses	—	—	—
Income From Cummulated Effect Of Accounting Changes	—	—	—
Income From Tax Loss Carryforward	—	—	—
Other Gains And Losses	—	—	—
Total Net Income	84,750	43,021	87,633
Normalized Income	85,903	87,408	88,692
NetIncome Available For Common	84,750	43,021	87,633
Preferred Dividends	—	—	—
Excise Taxes	—	—	—

	Dec 31, 2007	Dec 31, 2006	Dec 31, 2005
Operating revenue
Total Revenue	2,136,882	1,988,500	1,772,881
Operating Revenue	2,136,882	1,988,500	1,772,881
Adjustments To Revenue	—	—	—
Cost Of Sales	564,477	416,934	319,889
Cost Of Sales With Depreciation	566,534	419,808	322,985
Gross Operating Profit	1,572,405	1,571,566	1,452,992
Operating Expenses
Research And Development Expenses	149,425	143,596	74,015
Selling General And Administrative Expenses	691,034	713,965	636,483
Advertising Expenses	—	—	—
Operating Income Before Depreciation	731,946	714,005	742,494
Operating Income	227,513	402,546	180,079
Depreciation	175,920	150,423	150,145
Depreciation Unreconciled	173,863	147,549	147,049
Amortization	—	—	—
Amortization Of Intangibles	—	—	—
Operating Income After Depreciation	556,026	563,582	592,349
Non Operating Expenses
Interest Expense	7,818	9,857	11,931
Pre Tax Income	250,818	424,312	178,115
Income Taxes	67,600	135,730	61,485
Minority Interest	—	—	—
Income Before Income Taxes	250,818	424,312	178,115
Net Income From Continuing Operations	183,218	288,582	116,630
Net Income From Discontinued Operations	-237	367	1,203
Net Income From Total Operations	182,981	288,949	117,833
Non Recurring Events
Extraordinary Income Losses	—	—	—
Income From Cummulated Effect Of Accounting Changes	—	—	—
Income From Tax Loss Carryforward	—	—	—
Other Gains And Losses	—	—	—
Total Net Income	182,981	288,949	117,833
Normalized Income	511,731	448,990	530,575
NetIncome Available For Common	183,218	288,582	116,630
Preferred Dividends	—	—	—
Excise Taxes	—	—	—